Compound information
- Natural Products
- ZC2021624
- Molecular Formula
- C18H19BrN2O4S
- Molecular Weight
- 438.024890188 g/mol
- Structure
-
- IUPAC Name
- benzyl 4-(4-bromophenyl)sulfonylpiperazine-1-carboxylate
- InChI
- InChI=1S/C18H19BrN2O4S/c19-16-6-8-17(9-7-16)26(23,24)21-12-10-20(11-13-21)18(22)25-14-15-4-2-1-3-5-15/h1-9H,10-14H2
- InChI Key
- OGHZYGZZIMIERR-UHFFFAOYSA-N
- SMILES
- O=C(OCc1ccccc1)N1CCN(S(=O)(=O)c2ccc(Br)cc2)CC1
- Source
- ZINC000167975878
Warheads
- Carbamate
-
ADMET Property
Physicochemical Property
Property | Value | Property | Value |
---|---|---|---|
Heavy Atom Count | 26 | Ring Count | 3 |
Heteroatom Count | 8 | Rotatable Bond Count | 4 |
Hydrogen Bond Acceptor Count | 4 | Hydrogen Bond Donor Count | 0 |
Topological Polar Surface Area | 66.92 Å2 | LogP | 3.618 |
LogS | -5.222 | LogD | 4.086 |
Absorption
Property | Value | Property | Value |
---|---|---|---|
Pgp inhibitor | 0.137 | Pgp substrate | 0.245 |
HIA | 0.976 | F20 % | 0.993 |
F30 % | 0.823 | Caco-2 | -4.353 |
MDCK | -4.874 |
Distribution
Property | Value | Property | Value |
---|---|---|---|
BBB Penetration | 0.541 | PPB | 97.237 |
VD | 0.424 | Fu | 1.219 |
Metabolism
Property | Value | Property | Value |
---|---|---|---|
CYP1A2 inhibitor | 0.822 | CYP1A2 substrate | 0.662 |
CYP2A6 substrate | 0.49 | CYP2B6 substrate | 0.684 |
CYP2C19 inhibitor | 0.978 | CYP2C19 substrate | 0.81 |
CYP2C8 substrate | 0.843 | CYP2C9 inhibitor | 0.991 |
CYP2C9 substrate | 1.0 | CYP2D6 inhibitor | 0.178 |
CYP2D6 substrate | 0.942 | CYP2E1 substrate | 0.852 |
CYP3A4 inhibitor | 0.562 | CYP3A4 substrate | 0.998 |
Excretion
Property | Value | Property | Value |
---|---|---|---|
T1/2 | 0.288 | CL | 4.138 |
Toxicity
Property | Value | Property | Value |
---|---|---|---|
hERG Blockers | 0.907 | Hepatotoxicity | 0.993 |
Mutagenicity | 0.02 | Rat Oral Acute Toxicity | 0.34 |
FDAMDD | 0.881 | Skin Sensitization | 0.071 |
Carcinogenicity | 0.696 | Eye Corrosion | 0.007 |
Eye Irritation | 0.037 | Respiratory Toxicity | 0.205 |
Environmental Toxicity
Property | Value | Property | Value |
---|---|---|---|
Bioconcentration Factors | 0.565 | IGC50 | 3.846 |
LC50FM | 2.639 | LC50DM | 4.638 |
Tox21 Pathway
Property | Value | Property | Value |
---|---|---|---|
NR-AR | 0.146 | NR-AR-LBD | 0.366 |
NR-AhR | 0.092 | NR-Aromatase | 0.074 |
NR-ER | 0.35 | NR-ER-LBD | 0.403 |
NR-PPAR-gamma | 0.137 | SR-ARE | 0.714 |
SR-ATAD5 | 0.295 | SR-HSE | 0.128 |
SR-MMP | 0.036 | SR-p53 | 0.025 |
Similar covalent inhibitors
Similar covalent drugs
No similar covalent drugs found for this compound.